These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1198 related articles for article (PubMed ID: 12847684)

  • 1. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2.
    Kiriakidis S; Andreakos E; Monaco C; Foxwell B; Feldmann M; Paleolog E
    J Cell Sci; 2003 Feb; 116(Pt 4):665-74. PubMed ID: 12538767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of cell proliferation and soluble mediators induced by interleukin 1beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis.
    Inoue H; Takamori M; Nagata N; Nishikawa T; Oda H; Yamamoto S; Koshihara Y
    Inflamm Res; 2001 Feb; 50(2):65-72. PubMed ID: 11289656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
    Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
    Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis.
    Smeets TJ; Barg EC; Kraan MC; Smith MD; Breedveld FC; Tak PP
    Ann Rheum Dis; 2003 Jul; 62(7):635-8. PubMed ID: 12810425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor.
    Tsuchiya A; Imai K; Asamitsu K; Waguri-Nagaya Y; Otsuka T; Okamoto T
    J Pharmacol Exp Ther; 2010 Apr; 333(1):236-43. PubMed ID: 20053934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts.
    Hitchon C; Wong K; Ma G; Reed J; Lyttle D; El-Gabalawy H
    Arthritis Rheum; 2002 Oct; 46(10):2587-97. PubMed ID: 12384916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
    Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
    Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals.
    Cheon H; Yu SJ; Yoo DH; Chae IJ; Song GG; Sohn J
    Clin Exp Immunol; 2002 Mar; 127(3):547-52. PubMed ID: 11966774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.
    Georganas C; Liu H; Perlman H; Hoffmann A; Thimmapaya B; Pope RM
    J Immunol; 2000 Dec; 165(12):7199-206. PubMed ID: 11120852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs.
    Yoon HY; Lee EG; Lee H; Cho IJ; Choi YJ; Sung MS; Yoo HG; Yoo WH
    Int J Mol Med; 2013 Oct; 32(4):971-7. PubMed ID: 23934131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
    Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
    J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
    Tas SW; Adriaansen J; Hajji N; Bakker AC; Firestein GS; Vervoordeldonk MJ; Tak PP
    Hum Gene Ther; 2006 Aug; 17(8):821-32. PubMed ID: 16942442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.